SV

Sathyaseelan Vallomparambath Panikkassery

Director Additional Director DIN 08132608
DIN 08132608 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since May 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sathyaseelan Vallomparambath Panikkassery

Data last updated:

Sathyaseelan Vallomparambath Panikkassery was an Additional Director at Piyatho Health Care Private Limited (2018–2019). The company operates in Pharma.

DIN 08132608
Primary Designation Additional Director
Industry Pharma
First Appointment 14 May 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Piyatho Health Care Private Limited U36999KL2018PTC052815
Additional Director14 May 20182018₹1.97 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Piyatho Health Care Private Limited
Premium access

Shareholding and investment profile for Sathyaseelan Vallomparambath Panikkassery

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sathyaseelan Vallomparambath Panikkassery

Sathyaseelan Vallomparambath Panikkassery was first appointed on 14 May 2018 as Additional Director at Piyatho Health Care Private Limited.

Sathyaseelan Vallomparambath Panikkassery held 1 earlier board appointment: Piyatho Health Care Private Limited (Additional Director, 14 May 2018 to 10 Jun 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available